Treat or monitor early prostate cancer? 10-yr survival same : usnews

as mentioned in usnews

Treat or monitor early prostate cancer? 10-yr survival same

Treat or monitor early prostate cancer? 10-yr survival same

Douglas Collett, a retired construction worker from Cromhall, England, speaks about his prostate cancer diagnosis on Tuesday, Sept. 13, 2016.The 73-year-old says, "My initial reaction was to get rid of it."But after reading up on the risks and benefits of surgery and radiation, he feels more men should be fully informed about the various strategies.(AP Photo/APTN) The Associated PressBy MARIA CHENG, AP Medical WriterLONDON (AP) — Men with early prostate cancer who choose to closely monitor their disease are just as likely to survive at least 10 years as those who have surgery or radiation, finds a major study that directly tested and compared these options.


besides ctvnews

99% of men survive early prostate cancer, even if they skip treatment: study

99% of men survive early prostate cancer, even if they skip treatment: study

Jeff Lagerquist, CTVNews.ca StaffThere are three options for men diagnosed with prostate cancer: the scalpel, radiation, or the hands-off approach.It's a difficult decision, and experts have consistently said there is no right answer.However, a new British-based study published Wednesday in the New England Journal of Medicine suggests it may not matter which you choose since the risk of dying after 10 years is the same -- about one per cent."There's been no hard evidence that treating early disease makes a difference," said the study's chief investigator Dr. Freddie Hamdy of the University of Oxford in an interview with The Associated Press.


in like manner foxnews

Treat or monitor early prostate cancer? 10-year survival is the same, study says

Treat or monitor early prostate cancer? 10-year survival is the same, study says

Men with early prostate cancer who choose to closely monitor their disease are just as likely to survive at least 10 years as those who have surgery or radiation, finds a major study that directly tested and compared these options.Survival from prostate cancer was so high — 99 percent, regardless of which approach men had — that the results call into question not only what treatment is best but also whether any treatment at all is needed for early-stage cases.And that in turn adds to concern about screening with PSA blood tests, because screening is worthwhile only if finding cancer earlier saves lives."There's been no hard evidence that treating early disease makes a difference," said Dr. Freddie Hamdy of the University of Oxford, the study's leader.